ArticleNature cancer2022

Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.

Ashkan Shahbandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.